CVE Tools

CVE-2026-14996

Multiple vulnerabilities in IBM Aspera Faspex

No known exploitation. EPSS puts it in the 26th percentile. Fixed in 5.0.16.

Published Updated Sources: CVE.org, NVD

What to do

Find your product and version, then upgrade to the build on the right.

  • IBM Aspera Faspex 5Affected: ≥ 5.0.0, ≤ 5.0.15.4Upgrade to: after 5.0.15.4Stated by: CVE record
  • Ibm Aspera FaspexAffected: ≥ 5.0.0, < 5.0.16Upgrade to: 5.0.16Stated by: NVD

Versions as the sources state them. Full version matrix after sign-in

What it is

From the CVE record

IBM Aspera Faspex 5 5.0.0 through 5.0.15.4 has addressed a vulnerability related to session management.

In plain language

No plain-language summary for this CVE yet.

Exploitation

Where each signal puts this CVE on the scale from published to confirmed exploited.

EPSS26th
CISA KEV

Not in the catalog. CISA has not confirmed exploitation.

Public exploits

No public exploit or proof of concept found in the sources we track.

EPSS

0.3% chance of exploitation activity in the next 30 days, which ranks it in the 26th percentile of scored CVEs.

Exploit Prediction Scoring System, FIRST.org. A probability, not a confirmation.

Lifecycle

13 events over 87 days, from the signal feeds we watch.

  1. Patch availablerecord updated
  2. Patch availablerecord updated
  3. Patch availablerecord updated
  4. Patch availablerecord updated
  5. Patch availablepublished, weakness classified, att&ck mapped, record updated

Affected products

Technical detail

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:L/A:N

Scored 8.2 by NVD.

How it is reached

  • Attack Vector NetworkExploitable remotely over the network without any special conditions
  • Attack Complexity LowNo special conditions — the attack can be reliably reproduced
  • Privileges Required NoneNo authentication required — anyone can exploit this
  • User Interaction NoneNo user interaction needed — fully automated exploitation

Scope

  • Scope UnchangedImpact is limited to the vulnerable component itself

Impact if exploited

  • Confidentiality HighTotal information disclosure — all data in the component is compromised
  • Integrity LowData modification is possible but limited in scope or consequence
  • Availability NoneNo availability impact

Weaknesses

ATT&CK techniques

Mapped from the weaknesses above (CWE to ATT&CK), not observed in attacks.

Sources

References in the record

Watch the software you run.

My Stack ranks new CVEs for your products by real-world exploitation, so the next serious one reaches you without reading every advisory.

We'll flag the next CVE, public exploit or patch for Aspera Faspex 5, not every advisory.